Literature DB >> 31951003

Neuropathology of Speech Network Distinguishes Bulbar From Nonbulbar Amyotrophic Lateral Sclerosis.

Sanjana Shellikeri1,2, Julia Keith3, Sandra E Black2,4,5,6, Lorne Zinman2,4,5, Yana Yunusova1,2,7.   

Abstract

Bulbar amyotrophic lateral sclerosis (ALS) is a debilitating neurodegenerative subtype affecting speech and swallowing motor functions as well as associated with the burden of cognitive deficits. The neuroanatomical underpinnings of bulbar ALS are not well understood. The aim of this study was to compare neuropathology of the speech network (SpN) between 3 cases of bulbar-onset ALS (bALS), 3 cases of spinal-onset ALS (sALS) with antemortem bulbar ALS (sALSwB) against 3 sALS without antemortem bulbar ALS (sALSnoB) and 3 controls. Regional distribution and severity of neuronal loss, TDP-43 (transactive response DNA-binding protein of 43 kDa), and tau proteinopathy were examined. All 3 bALS cases showed marked neuronal loss and severe proteinopathy across most SpN regions; sALSwB cases showed no neuronal loss but mild and variable TDP-43 pathology in focal regions; sALSnoB cases demonstrated an absence of pathology. Two bALS cases had coexisting tauopathy in SpN regions, which was not noted in any sALS cases. The findings suggested that bALS may have a distinct neuropathological signature characterized by marked neuronal loss and polypathology in the SpN. Milder TDP-43 pathology in the SpN for sALSwB cases suggested a link between severity of bulbar ALS and SpN damage. Findings support a clinicopathologic link between bulbar symptoms and pathology in the SpN.
© 2019 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Amyotrophic lateral sclerosis (ALS); Bulbar; Frontotemporal lobar degeneration (FTLD); Immunohistochemistry; Neuropathology; Speech network

Mesh:

Substances:

Year:  2020        PMID: 31951003      PMCID: PMC7036661          DOI: 10.1093/jnen/nlz130

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  94 in total

1.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.

Authors:  Stephen C Bourke; Mark Tomlinson; Tim L Williams; Robert E Bullock; Pamela J Shaw; G John Gibson
Journal:  Lancet Neurol       Date:  2006-02       Impact factor: 44.182

2.  Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy.

Authors:  Anna Montuschi; Barbara Iazzolino; Andrea Calvo; Cristina Moglia; Leonardo Lopiano; Gabriella Restagno; Maura Brunetti; Irene Ossola; Anna Lo Presti; Stefania Cammarosano; Antonio Canosa; Adriano Chiò
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-04-25       Impact factor: 10.154

3.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

4.  Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS.

Authors:  P G Ince; J Evans; M Knopp; G Forster; H H M Hamdalla; S B Wharton; P J Shaw
Journal:  Neurology       Date:  2003-04-22       Impact factor: 9.910

5.  Relation between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis.

Authors:  S Abrahams; L H Goldstein; A Al-Chalabi; A Pickering; R G Morris; R E Passingham; D J Brooks; P N Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-05       Impact factor: 10.154

6.  Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients.

Authors:  Herbert Schreiber; Tanja Gaigalat; Ursula Wiedemuth-Catrinescu; Michael Graf; Ingo Uttner; Rainer Muche; Albert Christian Ludolph
Journal:  J Neurol       Date:  2005-03-08       Impact factor: 4.849

7.  Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis.

Authors:  Esther Verstraete; Jan H Veldink; Leonard H van den Berg; Martijn P van den Heuvel
Journal:  Hum Brain Mapp       Date:  2013-03-01       Impact factor: 5.038

Review 8.  The cognitive profile of ALS: a systematic review and meta-analysis update.

Authors:  Emma Beeldman; Joost Raaphorst; Michelle Klein Twennaar; Marianne de Visser; Ben A Schmand; Rob J de Haan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-17       Impact factor: 10.154

9.  A harmonized classification system for FTLD-TDP pathology.

Authors:  Ian R A Mackenzie; Manuela Neumann; Atik Baborie; Deepak M Sampathu; Daniel Du Plessis; Evelyn Jaros; Robert H Perry; John Q Trojanowski; David M A Mann; Virginia M Y Lee
Journal:  Acta Neuropathol       Date:  2011-06-05       Impact factor: 17.088

10.  Cortical thinning and clinical heterogeneity in amyotrophic lateral sclerosis.

Authors:  Domenico Maria Mezzapesa; Eustachio D'Errico; Rosanna Tortelli; Eugenio Distaso; Rosa Cortese; Marianna Tursi; Francesco Federico; Stefano Zoccolella; Giancarlo Logroscino; Franca Dicuonzo; Isabella Laura Simone
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

View more
  2 in total

1.  Psychometric Properties of Rapid Word-Based Rate Measures in the Assessment of Bulbar Amyotrophic Lateral Sclerosis: Comparisons With Syllable-Based Rate Tasks.

Authors:  Sanjana Shellikeri; Reeman Marzouqah; Benjamin Rix Brooks; Lorne Zinman; Jordan R Green; Yana Yunusova
Journal:  J Speech Lang Hear Res       Date:  2021-10-26       Impact factor: 2.674

2.  The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial.

Authors:  Eleonora Dalla Bella; Enrica Bersano; Giovanni Antonini; Giuseppe Borghero; Margherita Capasso; Claudia Caponnetto; Adriano Chiò; Massimo Corbo; Massimiliano Filosto; Fabio Giannini; Rossella Spataro; Christian Lunetta; Jessica Mandrioli; Sonia Messina; Maria Rosaria Monsurrò; Gabriele Mora; Nilo Riva; Romana Rizzi; Gabriele Siciliano; Vincenzo Silani; Isabella Simone; Gianni Sorarù; Valeria Tugnoli; Lorenzo Verriello; Paolo Volanti; Roberto Furlan; John M Nolan; Emmanuelle Abgueguen; Irene Tramacere; Giuseppe Lauria
Journal:  Brain       Date:  2021-10-22       Impact factor: 13.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.